Michelle Eagle

9.1k total citations · 1 hit paper
64 papers, 3.9k citations indexed

About

Michelle Eagle is a scholar working on Molecular Biology, Genetics and Biomedical Engineering. According to data from OpenAlex, Michelle Eagle has authored 64 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 14 papers in Genetics and 12 papers in Biomedical Engineering. Recurrent topics in Michelle Eagle's work include Muscle Physiology and Disorders (44 papers), Neurogenetic and Muscular Disorders Research (14 papers) and Genetic Neurodegenerative Diseases (9 papers). Michelle Eagle is often cited by papers focused on Muscle Physiology and Disorders (44 papers), Neurogenetic and Muscular Disorders Research (14 papers) and Genetic Neurodegenerative Diseases (9 papers). Michelle Eagle collaborates with scholars based in United Kingdom, United States and France. Michelle Eagle's co-authors include Kate Bushby, R. Bullock, Volker Straub, David Giddings, Colin Chandler, Simon Baudouin, Anna Mayhew, Patrick F. Chinnery, Fiona Norwood and John Bourke and has published in prestigious journals such as PLoS ONE, Brain and Neurology.

In The Last Decade

Michelle Eagle

63 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation

2002 702 citations Michelle Eagle, R. Bullock et al. Neuromuscular Disorders profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle Eagle United Kingdom	31	2.8k	896	856	669	602	64	3.9k
Kathi Kinnett United States	17	2.4k 0.9×	771 0.9×	728 0.9×	538 0.8×	285 0.5×	47	3.3k
Anne M. Connolly United States	38	2.6k 0.9×	924 1.0×	658 0.8×	454 0.7×	747 1.2×	132	4.9k
Emma Ciafaloni United States	35	2.8k 1.0×	766 0.9×	599 0.7×	297 0.4×	678 1.1×	113	4.3k
Linda Cripe United States	30	4.3k 1.6×	977 1.1×	2.4k 2.8×	783 1.2×	439 0.7×	87	6.0k
Carolyn M. Constantin United States	7	1.9k 0.7×	529 0.6×	483 0.6×	427 0.6×	223 0.4×	11	2.4k
Maria Grazia D’Angelo Italy	32	1.4k 0.5×	527 0.6×	277 0.3×	360 0.5×	535 0.9×	123	2.9k
Ajay Kaul United States	25	1.9k 0.7×	551 0.6×	476 0.6×	419 0.6×	248 0.4×	96	4.6k
Monique M. Ryan Australia	36	1.7k 0.6×	945 1.1×	597 0.7×	198 0.3×	1.2k 2.0×	207	4.1k
Susan Apkon United States	20	1.6k 0.6×	533 0.6×	414 0.5×	403 0.6×	162 0.3×	52	2.6k
David D. Kilmer United States	25	1.3k 0.5×	580 0.6×	235 0.3×	363 0.5×	585 1.0×	35	2.4k

Countries citing papers authored by Michelle Eagle

Since Specialization

Citations

This map shows the geographic impact of Michelle Eagle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Eagle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Eagle more than expected).

Fields of papers citing papers by Michelle Eagle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Eagle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Eagle. The network helps show where Michelle Eagle may publish in the future.

Co-authorship network of co-authors of Michelle Eagle

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Eagle. A scholar is included among the top collaborators of Michelle Eagle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Eagle. Michelle Eagle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

James, M., Kristy Rose, Lindsay N. Alfano, et al.. (2021). Remote Delivery of Motor Function Assessment and Training for Clinical Trials in Neuromuscular Disease: A Response to the COVID-19 Global Pandemic. Frontiers in Genetics. 12. 735538–735538. 8 indexed citations

James, M., Anna Mayhew, Michelle Eagle, et al.. (2017). Does the performance of upper limb capture functional variations in dysferlinopathy?. Neuromuscular Disorders. 27. S145–S146. 1 indexed citations

Landfeldt, Erik, Michelle Eagle, Volker Straub, et al.. (2017). Mortality Cost of Duchenne Muscular Dystrophy. Global & Regional Health Technology Assessment. 4(1). grhta.5000260–grhta.5000260. 2 indexed citations

McDonald, Craig M., K. Bushby, M. Tulinius, et al.. (2016). Ataluren: An Overview of Clinical Trial Results in Nonsense Mutation Duchenne Muscular Dystrophy (P3.162). Neurology. 86(16_supplement). 2 indexed citations

Connolly, Anne M., Julaine Florence, Mary Michaeleen Cradock, et al.. (2014). One Year Outcome of Boys With Duchenne Muscular Dystrophy Using the Bayley-III Scales of Infant and Toddler Development. Pediatric Neurology. 50(6). 557–563. 39 indexed citations

Willis, Tracey, Kieren G. Hollingsworth, Marie‐Louise Sveen, et al.. (2014). Quantitative Magnetic Resonance Imaging in Limb-Girdle Muscular Dystrophy 2I: A Multinational Cross-Sectional Study. PLoS ONE. 9(2). e90377–e90377. 71 indexed citations

McDonald, Craig M., Erik Henricson, Richard T. Abresch, et al.. (2013). The 6‐minute walk test and other clinical endpoints in duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle & Nerve. 48(3). 357–368. 235 indexed citations

Mayhew, Anna, Michelle Eagle, E. Scott, et al.. (2012). S.P.5 Trial readiness: Clinical interpretability of change scores of the North Star Ambulatory Assessment in Duchenne muscular dystropy. Neuromuscular Disorders. 22(9-10). 876–877. 1 indexed citations

Scarisbrick, Julia, Stephen Morris, Richard Azurdia, et al.. (2012). U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma. British Journal of Dermatology. 168(1). 192–200. 73 indexed citations

10.

Wagner, Matias, Amina Chaouch, Juliane Müller, et al.. (2012). Presymptomatic late-onset Pompe disease identified by the dried blood spot test. Neuromuscular Disorders. 23(1). 89–92. 8 indexed citations

11.

Mayhew, Anna, Stefan Cano, Elaine Scott, et al.. (2011). Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy. Developmental Medicine & Child Neurology. 53(6). 535–542. 84 indexed citations

12.

Scott, Elaine, Michelle Eagle, Anna Mayhew, et al.. (2011). Development of a Functional Assessment Scale for Ambulatory Boys with Duchenne Muscular Dystrophy. Physiotherapy Research International. 17(2). 101–109. 110 indexed citations

13.

Guglieri, Michela, Barbara E. Herr, Elaine McColl, et al.. (2010). P3.52 FOR-DMD: double-blind randomized trial to optimize steroid regime in Duchenne Muscular Dystrophy (DMD). Neuromuscular Disorders. 20(9-10). 657–657. 1 indexed citations

14.

Norwood, Fiona, et al.. (2009). Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain. 132(11). 3175–3186. 366 indexed citations

15.

Groen, Ewout J. N., R. Charlton, Rita Barresi, et al.. (2007). Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A. Brain. 130(12). 3237–3249. 64 indexed citations

16.

Hofman, D., et al.. (2007). Use of topical corticosteroids on chronic leg ulcers. Journal of Wound Care. 16(5). 227–230. 34 indexed citations

17.

Poppe, Maja, John Bourke, Michelle Eagle, et al.. (2004). Cardiac and respiratory failure in limb‐girdle muscular dystrophy 2I. Annals of Neurology. 56(5). 738–741. 81 indexed citations

18.

Eagle, Michelle, Jwalant Mehta, Kate Bushby, & Michael J. Gibson. (2004). IMPROVED SURVIVAL IN PATIENTS WITH SCOLIOSIS SECONDARY TO DUCHENNE MUSCULAR DYSTROPHY: THE ROLE OF SPINAL SURGERY AND NOCTURNAL VENTILATION. 117–117. 1 indexed citations

19.

Eagle, Michelle, et al.. (2000). Multicore myopathy: respiratory failure and paraspinal muscle contractures are important complications. Developmental Medicine & Child Neurology. 42(5). 340–343. 1 indexed citations

20.

Hoffman, Richard M., James E. Noble, & Michelle Eagle. (1999). The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care. 8(6). 273–276. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact